Securities code: Tinavi Medical Technologies Co.Ltd(688277) securities abbreviation: Tinavi Medical Technologies Co.Ltd(688277)
Tinavi Medical Technologies Co.Ltd(688277)
First quarter report 2022
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law. Important contents prompt that the board of directors, the board of supervisors, directors, supervisors and senior managers of the company guarantee that the contents of the quarterly report are true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities. The person in charge of the company, the person in charge of accounting and the person in charge of the accounting organization (Accounting Supervisor) ensure that the information in the financial statements in the quarterly report is true, accurate and complete. Whether the financial statements of the first quarter have been audited □ yes √ no I. main financial data (I) main accounting data and financial indicators
Unit: yuan currency: RMB
Increase or decrease in the current reporting period over the same period of the previous year (%)
Operating income 1715445917 -23.84
Net profit attributable to shareholders of listed companies – 2876800429 is not applicable
Net profit attributable to shareholders of listed companies after deducting non recurring profit and loss -3314288040
Net cash flow from operating activities -5008056865 is not applicable
Basic earnings per share (yuan / share) -0.07 not applicable
Diluted earnings per share (yuan / share) -0.07 not applicable
Weighted average return on net assets (%) – 2.90 not applicable
Total R & D investment 2109361930 – 14.37
The proportion of R & D investment in operating revenue (%) was 122.96, an increase of 13.60 percentage points
At the end of the reporting period, the change range of the end of the previous year compared with the end of the previous year (%)
Total assets 124180390609127905015142 -2.91
Owner’s equity attributable to shareholders of listed companies 97814897947100694723167 -2.86
（2） Non recurring profit and loss items and amounts
Unit: yuan currency: RMB
Description of current amount of the project
Gains and losses on disposal of non current assets -676447
Ultra vires approval, or there is no formal approval document, or occasional tax return, reduction or exemption of government subsidies included in the current profits and losses, except those closely related to the company’s normal business, in line with 579477180 national policies and regulations, and continuously enjoyed according to a certain standard quota or quota, which are included in the current profits and losses. The capital occupation fee charged to non-financial enterprises is obtained by subsidiaries The investment cost of associated enterprises and joint ventures is less than the income from the fair value of the identifiable net assets of the investee at the time of obtaining the investment. The profit and loss of non monetary asset exchange, the profit and loss of entrusting others to invest or manage assets, the profit and loss of various asset impairment reserves withdrawn due to force majeure factors, such as natural disasters, the profit and loss of debt restructuring, and the cost of enterprise restructuring, such as the expenses for resettling employees Profits and losses exceeding the fair value arising from transactions with significantly unfair transaction prices such as integration expenses. Net profits and losses of subsidiaries from the beginning of the period to the merger date arising from business combinations under the same control. Profits and losses arising from contingencies unrelated to the company’s normal business, in addition to effective hedging businesses related to the company’s normal business, held 125618324 trading financial assets, derivative financial assets, trading financial liabilities Profits and losses from changes in fair value arising from derivative financial liabilities, as well as profits and losses from the disposal of trading financial assets, derivative financial assets, trading financial liabilities, derivative financial liabilities and other creditor’s rights investment, receivables subject to impairment test separately, and the reversal of impairment reserves of contract assets back to entrusted loans
The profit and loss arising from the change of the fair value of the investment real estate subsequently measured by the fair value model shall be adjusted at one time according to the requirements of tax, accounting and other laws and regulations. The impact on the current profit and loss is the custody fee income obtained from the entrusted operation
Other non operating income and expenses other than the above 500000
Other profit and loss items that meet the definition of non recurring profit and loss
Less: income tax impact 26484381
Influence amount of minority shareholders’ equity (after tax) 240947065
Total 437487611
Description of defining the non recurring profit and loss items listed in the explanatory announcement on information disclosure of companies offering securities to the public No. 1 – non recurring profit and loss as recurring profit and loss items □ applicable √ not applicable (III) changes in main accounting data and financial indicators, reasons √ applicable □ not applicable
Project name change proportion (%) main reasons
The net cash flow from operating activities decreased compared with the same period of last year
The cash generated from operating activities was 397585 million yuan, mainly due to: on the one hand, the net political flow received during the reporting period from the beginning of the year to this report was not applicable, and the government subsidy decreased significantly compared with the same period of the previous year, resulting in the year-on-year decrease of other cash received related to operating activities at the end of the reporting period; On the other hand, the cash paid for purchasing goods and receiving labor services increased significantly compared with the same period of the previous year.
2、 Shareholder information (I) total number of ordinary shareholders, number of preferred shareholders whose voting rights have been restored and shareholding of the top ten shareholders
Unit: shares
Total number of common shareholders at the end of the reporting period 16639 total number of shareholders of non applicable preferred shares whose voting rights are restored at the end of the reporting period (if any)
Shareholding of top 10 shareholders
The number of shares held by shareholders including refinancing pledge, marking or freezing, shareholding ratio and lending shares of restricted strip pass
Shareholder name quality example (%) restricted sale of shares
Stock certificate quantity stock quantity status
Zhang Songgen has no natural person since 7566418.0275664, 000
Beijing Zhihui Hechuang Investment Co., Ltd. is a domestic non 33045,
State owned law of partnership enterprise (limited partnership), 560 7.87, 5600 people
Advanced manufacturing industry investment base domestic non 25523
Gold (limited partnership) state owned law, 412 6.08 0 none
Beijing Tianjin Hebei industry coordinated development domestic non 25523
State owned investment fund (412008) with limited partners
Within the territory of Wuqi, 125084 natural persons have been frozen since 125082.98 0, 400 00
Jiang Wenjun has no natural people since 112902.69, 000
Pingxiang jiuzhaoyuechen investment domestic non-10037
Management of partnership (limited state law, 213239 0 no partnership)
Beijing Runxin Dingtai invested 9500 in China and Africa,
Xin (limited partnership) state owned law 700 2.26 0 0 none 0
